Allen & Overy advises CORESTATE on the admission of new shares from a capital increase

The relevant securities prospectus was approved by the Luxembourg Financial Supervisory Authority (CSSF) on 28 June 2021. The new CORESTATE shares were admitted to trading on the regulated market (Prime Standard) of the Frankfurt Stock Exchange on 1 July 2021.

CORESTATE is a leading investment manager and co-investor in Europe with assets under management of approximately EUR 28 billion. The company sees itself as a manager for the entire real-estate value-added chain, and through its fully integrated real-estate platform offers investors in particular the opportunity to invest in major social trends such as urbanisation, demographic change and sustainability, which are likely to continue to have a major impact on residential, living and working environments in the long term.

CORESTATE is listed on the Frankfurt Stock Exchange and operates in 13 countries across Europe as an esteemed business partner for institutional and semi-institutional investors, as well as high-net-worth private investors, maintaining regional offices in Frankfurt, Vienna, Zurich, Paris, Madrid and London.

Allen & Overy's team was led by partner Dr Knut Sauer (Capital Markets, Frankfurt) and included partner Dr Christian Eichner, counsel Dr Michael Fink and Kyrill Chilevych (all Corporate/M&A, Duesseldorf), senior associate Nadine Kämper and associate Martin E. Kalbhenn (both Capital Markets, Frankfurt). Partner Paul Peporte, counsel Serge Zeien and juriste David Micheli (all Capital Markets, Luxembourg) advised on Luxembourg law.

CORESTATE also contributed an in-house team which was led by Daniel Löhken (Chief Legal & HR Officer and member of CORESTATE's management board) and comprised Dr Katharina Kneisel (Group Head of Legal), Qutaibah Sabeeh (Senior Legal Counsel) and Patrick Ehrich (Legal Counsel).